KROS (STOCKS)
Keros Therapeutics, Inc. Common Stock
$11.150000
-0.055000 (-0.49%)
Prev close: $11.205000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jasbir S. Seehra
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $219.65M
- Employees
- 82
- P/E (TTM)
- 4.88
- P/B (TTM)
- 0.72
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $243.86M |
| Benefits Costs and Expenses | $151.97M |
| Costs And Expenses | $151.97M |
| Nonoperating Income/Loss | $24.33M |
| Operating Expenses | $176.49M |
| Research and Development | $129.64M |
| Other Operating Expenses | $46.85M |
| Operating Income/Loss | $67.57M |
| Income/Loss From Continuing Operations After Tax | $87.01M |
| Income/Loss From Continuing Operations Before Tax | $91.90M |
| Income Tax Expense/Benefit | $4.88M |
| Income Tax Expense/Benefit, Current | $4.88M |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | $87.01M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $87.01M |
| Net Income/Loss Available To Common Stockholders, Basic | $87.01M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.34 |
| Diluted Earnings Per Share | $2.30 |
| Basic Average Shares | 37,221,211 |
| Diluted Average Shares | 37,859,106 |
| Assets | $338.02M |
| Current Assets | $315.43M |
| Noncurrent Assets | $22.59M |
| Fixed Assets | $4.30M |
| Other Non-current Assets | $18.29M |
| Liabilities | $34.89M |
| Current Liabilities | $20.41M |
| Accounts Payable | $1.97M |
| Wages | $5.87M |
| Other Current Liabilities | $12.58M |
| Noncurrent Liabilities | $14.48M |
| Equity | $303.13M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $303.13M |
| Liabilities And Equity | $338.02M |
| Net Cash Flow From Operating Activities | $107.51M |
| Net Cash Flow From Operating Activities, Continuing | $107.51M |
| Net Cash Flow From Investing Activities | -$1.55M |
| Net Cash Flow From Investing Activities, Continuing | -$1.55M |
| Net Cash Flow From Financing Activities | -$378.47M |
| Net Cash Flow From Financing Activities, Continuing | -$378.47M |
| Net Cash Flow | -$272.52M |
| Net Cash Flow, Continuing | -$272.52M |
| Comprehensive Income/Loss | $87.01M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $87.01M |
| Other Comprehensive Income/Loss | $0.00 |